BridgeMD
New treatment option for Type 2 Diabetes
Official title Glucose Monitoring After Acute Myocardial Infarct in People With Diabetes
ClinicalTrials.gov ID: NCT05431296
What this study is testing
- What it's testing
- Glucose monitoring after Acute Myocardial infarct in people with diabetes is a Dexcom funded study that is investigating whether the use of continuous glucose monitors (Dexcom ONE model) in people with type 2 diabetes facilitates time in glycaemic range in the 6 months after an acute myocardial infarction. As an exploratory outcome it will investigate whether time in glycaemic range is associated with changes in mortality and major adverse cardiac events in the 6 months after acute myocardial infarct.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- From the Hammersmith Hospital In-patient Cardiology Services:
- Adults aged \>18 years
- Known or newly diagnosed type 2 diabetes
- Taking one or more oral hypoglycaemic agent, GLP1 receptor analogue and/or insulin
- Admitted to Hammersmith Hospital cardiology inpatient services with ACS
You likely can't join if
- From the Hammersmith Hospital In-patient Cardiology Services:
- HbA1c \<48mmol/mol
- People who have previously had bariatric surgery
- People taking hydroxyurea
- People who undergo haemodialysis or peritoneal dialysis
- Unable to participate due to other factors, as assessed by the Chief Investigators
See the full eligibility criteria
- From the Hammersmith Hospital In-patient Cardiology Services:
- Adults aged \>18 years
- Known or newly diagnosed type 2 diabetes
- Taking one or more oral hypoglycaemic agent, GLP1 receptor analogue and/or insulin
- Admitted to Hammersmith Hospital cardiology inpatient services with ACS
- Raised blood troponin level on admission From Imperial College Healthcare Trust Diabetes and Cardiology Clinics:
- Adults aged \>18 years
- Known type 2 diabetes
- Previous acute coronary syndrome within the last 10 years but \> 6 months ago
- Taking one or more oral hypoglycaemic agent and /or GLP1 receptor analogue, and/or insulin
- From the Hammersmith Hospital In-patient Cardiology Services:
- HbA1c \<48mmol/mol
- People who have previously had bariatric surgery
- People taking hydroxyurea
- People who undergo haemodialysis or peritoneal dialysis
- Unable to participate due to other factors, as assessed by the Chief Investigators
- Pregnancy as determined by clinical team
- Known to have a terminal condition or conditions that suggest a life expectancy less than 1 year From Imperial College Healthcare Trust Diabetes and Cardiology Clinics:
- HbA1c \<48mmol/mol
- People who have previously had bariatric surgery
- People taking hydroxyurea
- People who undergo haemodialysis or peritoneal dialysis
- Unable to participate due to other factors, as assessed by the Chief Investigators
- Pregnancy as determined by clinical team
- Known to have a terminal condition or conditions that suggest a life expectancy less than 1 year
- Previous acute coronary syndrome more than 10 years ago or within the last 6 months Withdrawal criteria
- The subject has a serious event related to the study
- Investigated initiated discontinuation of study due to participation or equipment concerns
- Withdrawal of consent
The study team makes the final eligibility decision.
Where it's taking place
- London, United Kingdom
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include London, United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.